Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 4,716,423 | 4,377,348 | 4,097,507 | 3,171,617 | 2,683,049 |
| Cost of Goods | 400,262 | 382,104 | 401,989 | 335,192 | 274,383 |
| Gross Profit | 4,316,161 | 3,995,244 | 3,695,518 | 2,836,425 | 2,408,666 |
| Operating Expenses | 3,067,534 | 2,699,921 | 2,482,896 | 2,056,845 | 1,969,029 |
| Operating Income | 1,248,889 | 1,295,427 | 1,213,611 | 779,772 | 440,020 |
| Other Income | -18,983 | 37,252 | -57,728 | 72,396 | 52,143 |
| Pre-tax Income | 1,229,906 | 1,332,679 | 1,155,883 | 852,168 | 492,163 |
| Income Tax | 331,333 | 355,617 | 365,776 | 272,423 | 278,431 |
| Net Income Continuous | 898,573 | 977,062 | 790,107 | 579,745 | 213,732 |
| Minority Interests | -106,700 | 6,930 | 6,940 | -58,427 | N/A |
| Net Income | $1,005,273 | $970,132 | $783,167 | $638,172 | $217,511 |
| EPS Basic Total Ops | 3.98 | 3.37 | 2.67 | 2.02 | 0.64 |
| EPS Basic Continuous Ops | 3.56 | 3.40 | 2.70 | 1.84 | 0.63 |
| EPS Diluted Total Ops | 3.94 | 3.35 | 2.65 | 1.99 | 0.63 |
| EPS Diluted Continuous Ops | 3.53 | 3.38 | 2.68 | 1.81 | 0.62 |
| EBITDA(a) | $1,604,633 | $1,723,388 | $1,675,670 | $1,160,065 | $815,890 |